chartexchange

IMNM
Immunome, Inc.
stockNASDAQ

Market OpenNov 19, 2026 3:08:09 PM EST
16.55USD-1.371%(-0.23)425,161
Pre-marketNov 19, 2026 8:58:30 AM EST
16.80USD+0.119%(+0.02)
16.54Bid16.58Ask0.04Spread

IMNM Financials

In Q3 FY 2026 (ended ), Immunome, Inc. (IMNM) reported revenue of $0, net income of −$85.78M, operating cash flow of −$60.75M, and assets of $505.53M (filed ).

Loading financial statements…